CRAMS Provider Appoints Vice President and General Manager of Large Scale Manufacturing

AMRI has promoted Richard A. Saffee to the newly created role of Vice President and General Manager of Large Scale Manufacturing. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice President of Pharmaceutical Development and Manufacturing.

Saffee will assume oversight for large scale manufacturing in Aurangabad, India, in addition to his current responsibilities for leadership of AMRI’s large scale manufacturing and GMP business in the US in the Capital Region of New York. Additionally, he will work with AMRI’s Holywell, UK site to assist in its large scale manufacturing business. Saffee will be positioned to drive synergies between the locations that will improve quality, efficiency and delivery of world class APIs.   

“We are pleased to announce this promotion of Mr. Saffee,” said Dr. Hagen. “He joined AMRI in 2009 with more than 23 years of industrial and leadership experience in the chemical manufacturing of bulk APIs for both human and animal health. Since joining AMRI, his leadership has been instrumental in many successes achieved at the Rensselaer large scale manufacturing location. We look forward to his leadership in our continued efforts to achieve closer integration among all of our manufacturing facilities.”

Backed by an excellent compliance history and track record, AMRI’s worldwide manufacturing facilities are equipped for Phase I through commercial API manufacturing. As a part of AMRI’s SMARTSOURCING initiative, this closer integration of facilities under Saffee provides an added advantage as customers move their compounds from early development to high potency and large scale manufacturing. These global sites in the US, Europe and Asia also provide tailored solutions for the biotechnology and pharmaceutical industry and enable the efficient, cost-effective transfer of products and projects. AMRI also provides raw materials and starting materials for cGMP manufacturing of API.

Before coming to AMRI, Saffee led manufacturing activities for multiple US-based operations for Pfizer Global Manufacturing and Pfizer Global Human Health. Prior to the acquisition of Parke-Davis by Pfizer, Saffee held roles of increasing responsibility at Parke-Davis, including Director of Chemical Manufacturing and Area Production Manager. He has extensive knowledge in the areas of chemical manufacturing, technology transfer, regulatory compliance and quality standards, purchasing and materials management and managing global relationships. He is also trained in Lean Six Sigma techniques.

Saffee earned a Master’s degree in Business Administration from Grand Valley State University in Allendale, Michigan, US, and a Bachelor’s of Science degree in Chemical Engineering from the University of Michigan in Ann Arbor, Michigan.

Albany Molecular Research, Inc. (AMRI), +1 518 512 2512, www.amriglobal.com.